Answers are grounded in this paper and cite their sources.
Automated breast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) segmentation could facilitate quantitative tumor measurement, but geometric overlap alone does not establish the fidelity of mask-derived measurements. We developed an enhancement-aware three-dimensional MedNeXt framework with gated skip fusion and boundary supervision and evaluated it in a retrospective multi-cohort design spanning locked internal testing, source-held-out assessment, retrospective external validation, and radiologist review. Measurement fidelity was the primary endpoint. Across 521 paired internal-test and DUKE cases, median errors were 9.7% for tumor volume, 1.8 mm for 3D maximum surface diameter, and 10.2% for operational enhancement-defined volume, with corresponding ICCs of 0.97, 0.80, and 0.97. Median Dice was 0.831 internally and 0.823 in the DUKE source-held-out stratum, and was 0.812 and 0.806 in the BC-MRI-SEG and public BreastDCEDL_AMBL retrospective external-validation cohorts, respectively, using the frozen checkpoint without external-label tuning. No major correction was required for 78 of 80 masks in the blinded two-reader review. In 276 paired response-analysis cases, AUROC was 0.732 with automatic geometry and 0.757 with expert geometry (difference, −0.025; 95% CI, −0.095 to 0.045); discrimination non-inferiority was not demonstrated. These findings support automated segmentation as a starting point for radiologist-supervised retrospective quantitative research within the evaluated cohorts, while distinguishing measurement fidelity from downstream predictive equivalence.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: